A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia

  1. Garcia-Gutierrez, V.
  2. Gomez-Casares, M.T.
  3. Puerta, J.M.
  4. AlonsoDominguez, J.M.
  5. Osorio, S.
  6. Hernandez-Boluda, J.C.
  7. Collado, R.
  8. Ramirez, M.J.
  9. Ibañez, F.
  10. Martin, M.L.
  11. Rodriguez-Gambarte, J.D.
  12. Martinez-Laperche, C.
  13. Gomez, M.
  14. Fiallo, D.V.
  15. Redondo, S.
  16. Rodriguez, A.
  17. Ruiz-Nuño, C.
  18. Steegmann, J.L.
  19. Velasco, A.J.
Revue:
PLoS ONE

ISSN: 1932-6203

Année de publication: 2017

Volumen: 12

Número: 3

Type: Article

DOI: 10.1371/JOURNAL.PONE.0173532 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus